Amgen (AMGN): FY26 Q1 earnings call, Apr 30, 2026
No Kalshi or Polymarket word markets were listed for Amgen’s Apr 30, 2026 earnings call (FY26 Q1). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
1 match for “Prolia”; 1 quoted, at least 25 words apart.
…gaining traction and helping expand TEZSPIRE's reach across a broader patient population. Prolia and XGEVA combined delivered $1.1 billion in sales in the first quarter,…
Agents: this page as TSV at /api/v1/appearances/amgen:2026-04-30:earnings_call · words: /api/v1/brief?appearance=amgen:2026-04-30:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP